BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34070952)

  • 1. Long-Term Survival and Recurrence in Oropharyngeal Squamous Cell Carcinoma in Relation to Subsites, HPV, and p16-Status.
    Wendt M; Hammarstedt-Nordenvall L; Zupancic M; Friesland S; Landin D; Munck-Wikland E; Dalianis T; Näsman A; Marklund L
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 - Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas.
    Marklund L; Holzhauser S; de Flon C; Zupancic M; Landin D; Kolev A; Haeggblom L; Munck-Wikland E; Hammarstedt-Nordenvall L; Dalianis T; Näsman A
    Eur J Cancer; 2020 Nov; 139():192-200. PubMed ID: 32951963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival.
    Zupancic M; Kostopoulou ON; Holzhauser S; Lukoseviciute M; Jylhä C; Marklund L; Näsman A; Sivars L; Dalianis T
    Oral Oncol; 2024 Apr; 151():106749. PubMed ID: 38461771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma.
    Nordfors C; Grün N; Tertipis N; Ährlund-Richter A; Haeggblom L; Sivars L; Du J; Nyberg T; Marklund L; Munck-Wikland E; Näsman A; Ramqvist T; Dalianis T
    Eur J Cancer; 2013 Jul; 49(11):2522-30. PubMed ID: 23571147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of p16 and HPV DNA in non-tonsillar, non-base of tongue oropharyngeal cancer.
    Hammarstedt L; Holzhauser S; Zupancic M; Kapoulitsa F; Ursu RG; Ramqvist T; Haeggblom L; Näsman A; Dalianis T; Marklund L
    Acta Otolaryngol; 2021 Jan; 141(1):89-94. PubMed ID: 32940116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus and survival of patients per histological subsite of tonsillar squamous cell carcinoma.
    Haeggblom L; Attoff T; Hammarstedt-Nordenvall L; Näsman A
    Cancer Med; 2018 May; 7(5):1717-1722. PubMed ID: 29573210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years.
    Haeggblom L; Ramqvist T; Tommasino M; Dalianis T; Näsman A
    Papillomavirus Res; 2017 Dec; 4():1-11. PubMed ID: 29179862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model for predicting clinical outcome in patients with human papillomavirus-positive tonsillar and base of tongue cancer.
    Tertipis N; Hammar U; Näsman A; Vlastos A; Nordfors C; Grün N; Ährlund-Richter A; Sivars L; Haeggblom L; Marklund L; Hammarstedt-Nordenvall L; Chaturvedi AK; Munck-Wikland E; Ramqvist T; Bottai M; Dalianis T
    Eur J Cancer; 2015 Aug; 51(12):1580-7. PubMed ID: 26025766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein Expression in Tonsillar and Base of Tongue Cancer and in Relation to Human Papillomavirus (HPV) and Clinical Outcome.
    Ramqvist T; Näsman A; Franzén B; Bersani C; Alexeyenko A; Becker S; Haeggblom L; Kolev A; Dalianis T; Munck-Wikland E
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class I and II expression in oropharyngeal squamous cell carcinoma in relation to tumor HPV status and clinical outcome.
    Näsman A; Andersson E; Marklund L; Tertipis N; Hammarstedt-Nordenvall L; Attner P; Nyberg T; Masucci GV; Munck-Wikland E; Ramqvist T; Dalianis T
    PLoS One; 2013; 8(10):e77025. PubMed ID: 24130830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in incidence and prevalence of human papillomavirus in tonsillar and base of tongue cancer during 2000-2016 in the Stockholm region and Sweden.
    Haeggblom L; Attoff T; Yu J; Holzhauser S; Vlastos A; Mirzae L; Ährlund-Richter A; Munck-Wikland E; Marklund L; Hammarstedt-Nordenvall L; Ye W; Ramqvist T; Näsman A; Dalianis T
    Head Neck; 2019 Jun; 41(6):1583-1590. PubMed ID: 30584688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: a stabilisation of an epidemic of viral induced carcinoma?
    Näsman A; Nordfors C; Holzhauser S; Vlastos A; Tertipis N; Hammar U; Hammarstedt-Nordenvall L; Marklund L; Munck-Wikland E; Ramqvist T; Bottai M; Dalianis T
    Eur J Cancer; 2015 Jan; 51(1):55-61. PubMed ID: 25466506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
    Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
    Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of HPV-status on survival of patients with tonsillar carcinomas (TSCC) treated by CO
    Hoffmann M; Quabius ES; Tribius S; Gebhardt S; Görögh T; Hedderich J; Huber K; Dunst J; Ambrosch P
    Cancer Lett; 2018 Jan; 413():59-68. PubMed ID: 29100961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus is a favourable prognostic factor in cancer of unknown primary in the head and neck region and in hypopharyngeal cancer.
    Sivars L; Bersani C; Grün N; Ramqvist T; Munck-Wikland E; Von Buchwald C; Dalianis T
    Mol Clin Oncol; 2016 Dec; 5(6):671-674. PubMed ID: 28105346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of protein p16
    Yang H; Cao Y; Li ZM; Li YJ; Jiang WQ; Shi YX
    Oncol Lett; 2018 Nov; 16(5):6147-6155. PubMed ID: 30333880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3.
    Bersani C; Sivars L; Haeggblom L; DiLorenzo S; Mints M; Ährlund-Richter A; Tertipis N; Munck-Wikland E; Näsman A; Ramqvist T; Dalianis T
    Oncotarget; 2017 May; 8(21):35339-35350. PubMed ID: 28525363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer.
    Carpén T; Sorsa T; Jouhi L; Tervahartiala T; Haglund C; Syrjänen S; Tarkkanen J; Mohamed H; Mäkitie A; Hagström J; Mattila PS
    Cancer Immunol Immunother; 2019 Aug; 68(8):1263-1272. PubMed ID: 31240326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.